NAUT
NASDAQ · Life Sciences Tools & Services
Nautilus Biotechnology Inc
$2.14
-0.29 (-11.93%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,141.1% upside
Low Target
$24.26
Average Target
$26.56
High Target
$41.87
Current Price
$2.14
Current
$2.14
$2.14
Target
$26.56
$26.56
$24.26
$26.56 avg
$41.87
Scenario Analysis
Bear Case
$24.26
1,033.6%
Low target
Base Case
$26.56
+1,141.1%
Avg target
Bull Case
$41.87
+1,856.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.31
-50.3% from high
52-Week Low
$0.84
+154.4% from low
Target vs 52W High
$26.56
+516.2% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 34 | 79% | $369.21 | -46.4% |
| DHR | Strong Buy | 31 | 84% | $158.11 | -30.5% |
| A | Buy | 30 | 73% | $64.69 | -63.1% |
| WAT | Strong Buy | 28 | 75% | $189.60 | -58.5% |
| IQV | Strong Buy | 26 | 92% | $82.96 | -66.9% |
| MTD | Hold | 19 | 47% | $170.43 | -90.0% |
| ILMN | Hold | 28 | 54% | $169.36 | -15.6% |
| WST | Strong Buy | 21 | 95% | $136.24 | -65.7% |